<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01419405</url>
  </required_header>
  <id_info>
    <org_study_id>2011/1380-1</org_study_id>
    <nct_id>NCT01419405</nct_id>
  </id_info>
  <brief_title>Pregabalin and Remifentanil - Analgesia and Ventilation</brief_title>
  <official_title>Pregabalin Has Additive Analgesic and Ventilatory Depressive Effects in Combination With Remifentanil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this experimental study on healthy volunteers we explored the effect of pregabalin alone
      and in combination with remifentanil on acute experimental pain and ventilatory function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pain during cold pressor test (CPT) was scored at all dose levels of remifentanil on a visual
      analogue scale (VAS 0-100 mm). Ventilatory function was measured by spirometry registering
      respiratory frequency (breaths/min), minute volume (L/min) and expiratory end-tidal carbon
      dioxide tension (mmHg).

      Side effects such as nausea and sedation were registered.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>123 sec x 4</time_frame>
    <description>Pain was caused by Cold Pressure Test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ventilatory function</measure>
    <time_frame>10 min x 4</time_frame>
    <description>Respiratory frequence (breath/min), tidal volume (mL), minute volume (L)and expiratory end-tidal carbon dioxide tension (mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>4 min x 4</time_frame>
    <description>Cognitive function was tested using pc-tests like Cambridge Neuropsychological Test Automated Battery (CANTAB) and Stroop-test</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Pregabalin/placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo/remifentanil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo/placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregabalin/Remifentanil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>hard capsule, 150 mg, 2 times, 2 days</description>
    <arm_group_label>Pregabalin/placebo</arm_group_label>
    <arm_group_label>Pregabalin/Remifentanil</arm_group_label>
    <other_name>Lyrica</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Remifentanil</intervention_name>
    <description>50-90 min: TCI 0.6 ng/mL, 100-140 min: 1.2 ng/mL, 150-190 min: TCI 2.4 ng/mL</description>
    <arm_group_label>placebo/remifentanil</arm_group_label>
    <arm_group_label>Pregabalin/Remifentanil</arm_group_label>
    <other_name>Ultiva</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sugar pill, saline infusion</intervention_name>
    <description>hard capsule, 150 mg, 2 times, 2 days, saline infusion</description>
    <arm_group_label>placebo/placebo</arm_group_label>
    <other_name>Laktose monohydrat</other_name>
    <other_name>NaCl 0,9%</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers,

          -  &gt; 18 yrs &lt; 55 yrs,

          -  negative pregnancy test

        Exclusion Criteria:

          -  Pregnancy,

          -  nursing,

          -  known heart-, lung- or liver disease,

          -  kidney failure/peptic ulcers,

          -  use of liver enzyme-inducing medications,

          -  known allergy against the medications used in the trial,

          -  use of psychotropic drugs, analgesics or alcohol used the last 24 hours before the
             trial,

          -  body weight &gt; 100 kg or 30% deviation from normal weight,

          -  participant in other studies during the last 2 months,

          -  individuals who do not master Norwegian language
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Audun Stubhaug, MD, DMedSci, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital HF, Division of Critical Care</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oslo Universitetssykehus, Rikshospitalet</name>
      <address>
        <city>Oslo</city>
        <zip>0424</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2011</study_first_submitted>
  <study_first_submitted_qc>August 17, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2011</study_first_posted>
  <last_update_submitted>September 11, 2014</last_update_submitted>
  <last_update_submitted_qc>September 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 12, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>analgesia</keyword>
  <keyword>acute experimental pain</keyword>
  <keyword>cold pressor test</keyword>
  <keyword>pregabalin</keyword>
  <keyword>remifentanil</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

